One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Alcohol and Cannabis Use Disorders
Ned H. Kalin, M.D.
doi : 10.1176/appi.ajp.2021.21111134
Volume 179, Issue 1
Intricacies of Researching Cannabis Use and Use Disorders Among Veterans in the United States
Catherine W. Striley, Ph.D., M.S.W., Carolin C. Hoeflich, M.S.
Cannabis and Psychosis: Recent Epidemiological Findings Continuing the “Causality Debate�
Suhas Ganesh, M.D., Deepak Cyril D’Souza, M.D.
Substance Use Disorders Are Deadly
Wilson M. Compton, M.D., M.P.E., Beth Han, M.D., Ph.D.
Identifying and Reducing Bias in Genome-Wide Association Studies of Alcohol-Related Traits
Henry R. Kranzler, M.D., Hang Zhou, Ph.D., Rachel L. Kember, Ph.D.
Cannabis Use and the Endocannabinoid System: A Clinical Perspective
Margaret Haney, Ph.D.
Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III)
Kendall C. Browne, Ph.D., Malki Stohl, M.S., Kipling M. Bohnert, Ph.D., Andrew J. Saxon, M.D., David S. Fink, M.P.H., Mark Olfson, M.D., M.P.H., Magda
Association of Cannabis Use–Related Predictor Variables and Self-Reported Psychotic Disorders: U.S. Adults, 2001–2002 and 2012–2013
Ofir Livne, M.D., Dvora Shmulewitz, Ph.D., Aaron L. Sarvet, M.P.H., Melanie M. Wall, Ph.D., Deborah S. Hasin, Ph.D.
The Impact of Alcohol and Other Substance Use Disorders on Mortality in Patients With Eating Disorders: A Nationwide Register-Based Retrospective Cohort Study
Angelina Isabella Mellentin, Ph.D., Anna Mejldal, Ph.D., Maria Mercedes Guala, M.D., René Klinkby St?ving, M.D., Ph.D., Lene Stryhn Eriksen, M.D., Els
Item-Level Genome-Wide Association Study of the Alcohol Use Disorders Identification Test in Three Population-Based Cohorts
Travis T. Mallard, M.A., Jeanne E. Savage, Ph.D., Emma C. Johnson, Ph.D., Yuye Huang, Alexis C. Edwards, Ph.D., Jouke J. Hottenga, Ph.D., Andrew D. Gr
Is a Diagnosis of Schizophrenia Spectrum Disorder Associated With Increased Mortality in Patients With COVID-19?
Marina S?nchez-Rico, M.P.H.Frédéric Limosin, M.D., Ph.D.Nicolas Hoertel, M.D., Ph.D.
Comment on “Elevated C-Reactive Protein in Patients With Depression, Independent of Genetic, Health, and Psychosocial Factors: Results From the UK Biobank�
Mark Kvarta, M.D., Ph.D.Yizhou Ma, Ph.D.L. Elliot Hong, M.D.
